NCT06415396View on ClinicalTrials.gov

Effects of Extracorporeal Shock Wave Therapy (ESWT) and Low Intensity Laser Therapy (LLLT) Added to Complete Decongestive Therapy (CDT) on Extremity Volume, Pain Intensity, Functional Status and Quality of Life in Patients With Postmastectomy Stage 2 Lymphedema

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

June 20, 2023

Study Completion Date

June 25, 2023

Conditions
Lymphedema, Breast Cancer
Interventions
OTHER

Complete Decongestive Therapy

conventional CDT program consisting of MLD, compression bandage, skin care and lymphedema exercises, for a total of 15 sessions, five days a week for three weeks.

DEVICE

ESWT

ESWT was applied to the second group for a total of 5 sessions, 2 sessions in the first two weeks and 1 session in the last week. .

DEVICE

LLLT

In the third group, LLLT was applied for a total of 9 sessions, 3 sessions per week, in addition to conventional CDT.

Trial Locations (1)

06800

Ankara bilkent City Hospiatal Physical Therapy and Rehabilitation Hospital, Ankara

All Listed Sponsors
lead

Ankara City Hospital Bilkent

OTHER

NCT06415396 - Effects of Extracorporeal Shock Wave Therapy (ESWT) and Low Intensity Laser Therapy (LLLT) Added to Complete Decongestive Therapy (CDT) on Extremity Volume, Pain Intensity, Functional Status and Quality of Life in Patients With Postmastectomy Stage 2 Lymphedema | Biotech Hunter | Biotech Hunter